A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...
Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-edited cell therapy, eliminated vaso-occlusive crises in 97% of participants with severe sickle cell disease. The therapy led to substantial ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
In November 2023, the UK became the first country in the world to authorise a Crispr gene-editing therapy.
Hoosiers from across the state will gather at the Indiana State Capitol on Monday, Feb. 2, to call attention to the urgent ...
Sickle cell disease (SCD) can affect people of any ethnicity but is much more common among Africans and African Americans. Other ethnic groups with higher rates of SCD include Hispanic Americans from ...
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
WESTLAND, Mich. — For D’Asia Jackson, every day is a guessing game over whether excruciating pain will upend her life. The 28-year-old medical assistant was born with sickle cell disease, an inherited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results